Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis
Xiwei Yuan, Lu Li, Ying Zhang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2/GPX4 signaling pathway
Shuoxi Xu, Yonger Chen, Jindian Miao, et al.
Phytomedicine (2024) Vol. 128, pp. 155465-155465
Closed Access | Times Cited: 20
Ferroptosis in ulcerative colitis: Potential mechanisms and promising therapeutic targets
Dan Long, Chenhan Mao, Yingtao Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116722-116722
Open Access | Times Cited: 14
Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease
Yutong Sui, Xue Geng, Ziwei Wang, et al.
Metabolism (2024) Vol. 157, pp. 155953-155953
Closed Access | Times Cited: 10
The interplay of miRNAs and ferroptosis in diseases related to iron overload
Shikai Jin, Po‐Tsun Liu, Daheng Zheng, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 45-65
Closed Access | Times Cited: 15
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC)
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna Goussia, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 842-842
Open Access
Multi-approach analysis reveals the mechanism by which Shugan Xiaozhi decoction protects against metabolic dysfunction-associated steatohepatitis
Shuai Wang, Ruili Du, Jiahui Liu, et al.
Phytomedicine (2025) Vol. 141, pp. 156712-156712
Open Access
Inflammatory liver diseases and susceptibility to sepsis
Hong Lü
Clinical Science (2024) Vol. 138, Iss. 7, pp. 435-487
Closed Access | Times Cited: 4
Targeting cell death in NAFLD: mechanisms and targeted therapies
Huili Xu, Shengrong Wan, Ying An, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
Na Li, Liyuan Hao, Shenghao Li, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 8061-8083
Open Access | Times Cited: 2
Effects of Dityrosine on Lactic Acid Metabolism in Mice Gastrocnemius Muscle During Endurance Exercise via the Oxidative Stress-Induced Mitochondria Damage
Qiudong Xia, Jinchi Lan, Yuxiang Pan, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 10, pp. 5269-5282
Closed Access | Times Cited: 1
Western diet promotes the progression of metabolic dysfunction‐associated steatotic liver disease in association with ferroptosis in male mice
Nicole Maddie, Nefia Chacko, David Matatov, et al.
Physiological Reports (2024) Vol. 12, Iss. 23
Open Access | Times Cited: 1
Alterations in Glutathione Redox Homeostasis in Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review
Lucia Cesarini, Flavia Grignaffini, Anna Alisi, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1461-1461
Open Access
Page 1

Scroll to top